S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Kite Pharma, Inc. (KITE)
Kite Pharma, Inc. (KITE) Notícias

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:KITE

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/10/2017	18:05	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:KITE	Kite Pharma, Inc.
05/10/2017	16:44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	18:12	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	17:56	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	17:44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	10:03	Edgar (US Regulatory)	(25-NSE)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	09:46	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	09:45	Business Wire	Gilead Sciences Completes Acquisition of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	09:17	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	09:00	Business Wire	Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
26/09/2017	09:30	Business Wire	Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period	NASDAQ:KITE	Kite Pharma, Inc.
05/09/2017	17:13	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:KITE	Kite Pharma, Inc.
05/09/2017	13:24	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:KITE	Kite Pharma, Inc.
01/09/2017	18:28	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:KITE	Kite Pharma, Inc.
01/09/2017	18:22	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:KITE	Kite Pharma, Inc.
31/08/2017	19:23	PR Newswire (US)	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE	NASDAQ:KITE	Kite Pharma, Inc.
30/08/2017	13:50	Dow Jones News	FDA Approves First Gene Therapy in U.S. -- Update	NASDAQ:KITE	Kite Pharma, Inc.
30/08/2017	13:25	Dow Jones News	FDA Approves First Gene Therapy in U.S.	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	19:46	PR Newswire (US)	Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	04:02	Dow Jones News	Gilead Bets $11 Billion On New Cancer Therapy -- WSJ	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	04:02	Dow Jones News	What's News: Business & Finance -- WSJ	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	20:56	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion -- 2nd Update	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	13:26	Dow Jones News	The Promising New Cancer Treatment Behind Gilead's $11 Billion Deal	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	12:55	Business Wire	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	10:29	Dow Jones News	Hot Stocks to Watch in the U.S. and Canada	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	09:46	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion -- Update	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	08:00	Business Wire	Gilead Sciences to Acquire Kite Pharma for $11.9 Billion	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	07:59	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion in Cash	NASDAQ:KITE	Kite Pharma, Inc.
17/08/2017	09:30	Business Wire	Kite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo...	NASDAQ:KITE	Kite Pharma, Inc.
14/08/2017	18:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.